Aurora Cannabis Inc. (ACB) Stock Forecast
ACB analyst forecast
as of October 17, 2026- Analyst consensus
- Buy 3.80 / 5 from 5 analysts
- Price target
- $6.23 average of analyst targets
- Upside to target
- +56.1% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $-0.03
- 52-week range
- $2.58 – $5.57
ACB analyst ratings
5 analystsNumber of analysts at each rating.
ACB price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ACB earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.09 | −$0.19 | $0.00 | −$0.91 | +90.4% | 4 |
| Next quarter (Dec '26) | −$0.03 | −$0.11 | $0.01 | $0.03 | −208.3% | 4 |
| Current fiscal year (FY2027) | −$0.17 | −$0.49 | −$0.03 | −$2.14 | +92.0% | 6 |
| Next fiscal year (FY2028) | $0.11 | $0.07 | $0.15 | −$0.17 | +164.1% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ACB revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $72.6M | $69.6M | $76.0M | −19.6% | 5 |
| Next quarter (Dec '26) | $76.1M | $73.3M | $79.4M | −19.2% | 5 |
| Current fiscal year (FY2027) | $295.0M | $288.7M | $304.3M | −8.0% | 5 |
| Next fiscal year (FY2028) | $320.6M | $307.2M | $343.3M | +8.7% | 5 |
ACB EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ACB revenue: reported and forecast
ACB EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.14 | −$0.09 | −$0.09 | −$0.09 | −$0.09 | −37.5% | 1 up · 0 down |
| Next quarter (Dec '26) | −$0.08 | −$0.03 | −$0.03 | −$0.03 | −$0.03 | −60.6% | 1 up · 0 down |
| Current fiscal year (FY2027) | −$0.32 | −$0.17 | −$0.17 | −$0.17 | −$0.17 | −46.9% | 1 up · 0 down |
| Next fiscal year (FY2028) | $0.02 | $0.11 | $0.11 | $0.11 | $0.11 | +511.1% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ACB earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ACB beat in 7 of 12.
What analysts expect from ACB
5 analysts cover Aurora Cannabis; their consensus rating is buy (3.80 on a 1–5 scale, where 5 is a strong buy). The average price target is $6.23, 56.1% above the latest close of $3.99. Analysts expect earnings of −$0.17 per share for FY2027, +92.0% from a year earlier. For FY2028 the average estimate is $0.11 per share on revenue of $320.6 million. Aurora Cannabis beat the EPS estimate in 7 of the last 12 quarters.
Related: ACB income statement, ACB key metrics, ACB chart. See the ACB stock overview for the latest quote and news.
ACB forecast FAQ
What is Aurora Cannabis's price target?
The average analyst price target for Aurora Cannabis is $6.23, 56.1% above the latest close of $3.99.
Is Aurora Cannabis a buy, hold or sell?
Of 5 analysts covering Aurora Cannabis, 2 rate it a strong buy, 0 a buy, 3 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Aurora Cannabis's EPS forecast?
Analysts forecast −$0.17 per share for FY2027 (range −$0.49 to −$0.03); for FY2028 the estimate is $0.11.
What is Aurora Cannabis's revenue forecast?
The average revenue estimate for FY2027 is $295.0 million, growth of −8.0%; for FY2028 it is $320.6 million.
When does Aurora Cannabis report earnings?
Aurora Cannabis is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $-0.03.
Does Aurora Cannabis usually beat earnings estimates?
Aurora Cannabis reported EPS at or above the analyst estimate in 7 of the last 12 quarters.